A synergistic effect of Carica papaya latex sap and fluconazole on Candida albicans growth

Mycoses

Volumn 40, Issue 11-12, 1997, Pages 429-437

  Giordani, R ^a   Gachon, C ^a   Moulin Traffort, J ^a   Regli P ^a  

^a AIX MARSEILLE UNIVERSITY   (France)

Author keywords

Candida albicans; Carica papaya; Fluconazole; Latex sap; Synergistic effect

Indexed keywords

ANTIFUNGAL AGENT; FLUCONAZOLE; LATEX;

ARTICLE; CANDIDA ALBICANS; CONTROLLED STUDY; CULTURE MEDIUM; DRUG POTENTIATION; MICROBIAL GROWTH; NONHUMAN; PRIORITY JOURNAL; TRANSMISSION ELECTRON MICROSCOPY;

CANDIDA ALBICANS; CARICA PAPAYA;

EID: 0031469297     PISSN: 09337407     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1439-0507.1997.tb00180.x     Document Type: Article

References (37)

1. Giordani, R., Siepaio, M., Moulin-Traffort, J. & Régli, P. (1991) Antifungal action of Carica papaya latex: isolation of fungal cell wall hydrolysing enzymes, mycoses 34, 469-477.
2. Giordani, R., Cardenas, M. L., Moulin-Traffort, J. & Regli, P. (1995) Fungicidal activity of latex sap from Carica papaya and antifungal effect of D(+)-glucosamine on Candida albicans growth. mycoses 39, 103-110.
3. Esau, K. (1965) Secretory structures. In: J. Whiley and sons (ed.) Plant anatomy, New York, London, Sydney, 2nd edn, pp. 308-337.
4. Matile, Ph., Jans, B. & Rickenbacher, R. (1970) Vacuoles of Chelidonium latex: lysosomal property and accumulation of alkaloids. Biochem. Physiol. Pflanz. 161, 447-458.
5. Thureson-Klein, A. (1970) Observations of the development and fine structure of the articulated laticifers of Papaver somniferum. Ann. Bot. 34, 751-759.
6. Giordani, R. (1979) Ultrastructure des laticifères articulés de la laitue. C. R. Acad. Sci. Paris, D288, 615-618.
7. Giordani, R. & Lafon, L. (1993) Action of Carica papaya latex on cell wall glycosidases from Lactuca sativa pith. Phytochemistry 34, 1473-1475.
8. Washton, H. (1989) Review of fluconazole: a new triazole antifungal agent. Diagn. Infect. Dis. 12, 2295-2335.
9. Troke, P. F., Andrews, R. J., Pye, G. W. & Richarson, K. (1990) Fluconazole and other azoles: translation of in vitro activity to in vivo and clinical efficacy. Rev. Infect. Dis. (USA) 12 (Suppl. 3). 276-280.
10. Richarson, K., Cooper, K., Marriott, M. S., Tarbit, M. H., Troke, P. F. & Whittle, P. J. (1990) Discovery of fluconazole, a novel antifungal agent. Rev. Infect. Dis. (USA) 12 (Suppl. 3), 267-271.
11. Odds, F. G., Cheesman, S. L. & Abbott, A. B. (1986) Antifungal effects of fluconazole (UK 49858), a new triazole antifungal, in vitro. J. Antimicrob. Chemother. 18, 473-478.
12. Tucker, R. M., Galgiani, J. N., Denning, D. W., Hanson, L. H., Graybill, J. R., Sharkey, K., Eckman, M. R., Salemi, C., Libke, R., Klein, R. A. et al. (1990) Treatment of coccidioidal meningitis with fluconazole. Rev. Infect. Dis. (USA) 12 (Suppl. 3), 380-389.
13. Van Cauteren, H., Lampo, A., Vandenberghe, J., Vanparys, P., Coussement, W., De Coster, R. & Marsboom, R. (1989) Toxicological profile and safety evaluation of antifungal azole derivatives. mycoses 32 (Suppl. 1), 60-66..
14. Guillaume, M. P., De Prez, C. & Cogan, E. (1996) Subacute mitochondrial liver disease in a patient with AIDS: possible relationship to prolong fluconazole administration. Am. J. Gastroenterol. 91, 165-168.
15. National Committee for Clinical Laboratory Standards (1992) Reference method for broth dilution antifungal susceptibility testing for yeasts. Proposed standard M27-P. Villanova, PA.
16. Espinel-Ingroff, A., Kish, C. W., Kerkering, T. M., Frominding, R. A., Bartizal, K., Galgiani, J. N. et al. (1992) Collaborative comparison of broth macrodilution and microdilution antifungal susceptibility tests. J. Clin. Microbiol. 30, 3138-3145.
17. Bradford, M. M. (1976) A rapid and sensitive method for the quantitation of microgram quantities of protein utilizing the principle of protein-dye binding. Anal. Biochem. 72, 248-254.
18. Thiéry, J. P. (1967) Mise en évidence des polysaccharides sur coupes fines en microscopic électronique. J. Microscopic 6, 987-1018.
19. Medoff, G., Comfort, M., Kobayashi, G. S. (1971) Synergistic action of amphotericin B and 5-fluorocytosine against yeast-like organisms. Proc. Soc. Exp. Biol. Med. 138, 571-574.
20. Beggs, W. H., Sarosi, G. A. & Walker, M. I. (1976) Synergistic action of amphotericin B and rifampin against Candida species. J. Infect. Dis. 133, 206-209.
21. Hermann, J. L., Dubois, N., Fourgeaud, M., Basset, D. & Lagrange, P. H. (1994) Synergic inhibitory activity of amphotericin B and γ interferon against intracellular Cryptococcus neoformans in murine macrophages. J. Antimicrob. Chemother. 34, 1051-1058.
22. Moneib, N. A. (1995) In vitro activity of commonly used antifungal agents in the presence of rifampin, polymyxin B and norfloxacin against Candida albicans. J. Chemother. 7, 525-529.
23. Mary, C., Goudard, M., Blancard, A., Quilici, M. & Regli, P. (1989) Effect synergique entre la 5-flurocytosine et les dérivés imidazoles vis-à-vis de souches de levures résistantes à la 5-fluorocytosine. Ann. Biol. Clin. (Paris) 47, 546-549.
24. Brummer, E., Bhagavathula, P. R., Hanson, L. H. & Stevens, D. A. (1992) Synergy of itraconazole with macrophages in killing Blastomyces dermatidis. Antimicrob. Agents Chemother. 36, 2487-2492.
25. Garcha, U. K., Brummer, E. & Stevens, D. A. (1995) Synergy of fluconazole with human monocytes or monocyte-derived macrophages for killing of Candida species. J. Infect. Dis. 172, 1620-1623.
26. Nguyen, M. H., Barchiesi, F., McGough, D. A., Yu, V. L. & Rinaldi, M. G. (1995) In vitro evaluation of combination of fluconazole and flucytosine against Cryptococcus neoformans var. neoformans. Antimicrob. Agents Chemother. 39, 1691-1695.
27. Scott, E. M., Tariq, V. N. & McCrory, R. M. (1995) Demonstration of synergy with fluconazole and either ibuprofen, sodium salicylate or propylparaben against Candida albicans in vitro. Antimicrob. Agents Chemother. 39, 2610-2614.
28. Grover, D. D., Brummer, E. & Stevens, D. A. (1996) Study of the role of iron in the anticryptococcal activity of human serum and fluconazole. Mycopathologia 133, 71-77.
29. Garcha, U. K., Brummer, E. & Stevens, D. A. (1995a) Synergy of fluconazole with macrophages for antifungal activity against Candida albicans. Mycopathologia 132, 123-128.
30. Cassone, A. (1986) Cell wall of pathogenic yeasts and implications for antimycotic therapy. Drugs Exptl. Res. XII, 6/7, 635-643.
31. Eckhoff, G., Oelkers, W. & Bahr, V. (1988) Effects of two oral antimycotics, ketonazole and fluconazole, upon steroidogenesis in rat adrenal cells in vitro. J. Steroid Biochem. 31, 819-823.
32. Davies, D. A. L. & Pope, A. M. S. (1978) Mycolase, a new kind of systemic antimycotic. Nature 273, 235-236.
33. Pope, A. M. S. & Davies, D. A. L. (1979) The influence of carbohydrases on the growth of fungal pathogens in vitro and in vivo. Postgrad. Med. J. 55, 674-676.
34. Chalkley, L. J., Trinci, A. P. J. & Pope, A. M. S. (1985) Effect of mycolase and amphotericin B on Candida albicans and Candida pseudotropicalis in vitro and in vivo. Sabouraudia: J. Med. Vet. Mycol. 23, 147-164.
35. Rex, J. H., Rinaldi, M. G. & Pfaller, M. A. (1995) Resistance of Candida species to fluconazole. Antimicrob. Agents Chemother. 39, 1-8.
36. Giordani, R., Benyahia, S., Teissère, M. & Noat, G. (1992) Purification and properties of N-acetyl-β-D-glucosaminidase from Hivea brasiliensis latex. Plant Sci. 84, 25-34.
37. Giordani, R. & Noat, G. (1988) Isolation, molecular properties and kinetics studies of a strict β-fucosidase from Lactuca sativa latex. Its possible role in the cell-wall degradation of articulated laticifers. Eur. J. Biochem. 175, 619-625.